Press release
Top Market Shifts Transforming the Enteric Disease Testing Market Landscape: Key Insights
Enteric Disease Testing Market
What Is the Expected CAGR for the Enteric Disease Testing Market Through 2025?
The market size for enteric disease testing has seen robust growth in the past few years. Its expansion is projected to continue, moving from a value of $4.62 billion in 2024 up to $4.87 billion in 2025 with a compound annual growth rate (CAGR) of 5.4%. Factors such as water and food safety issues, spike in outbreak and epidemic occurrences, internationalization of food supplies, rising infections related to travel, and adherence to regulatory standards have all contributed to the growth experienced in the historical period.
What's the Projected Size of the Global Enteric Disease Testing Market by 2029?
The market size for enteric disease testing is anticipated to experience robust growth in the upcoming years, expanding to a value of $6.29 billion in 2029 with a CAGR of 6.6%. Several factors driving the growth during the forecast period include the implementation of telemedicine and remote monitoring, effects of climate change, intersectoral collaboration, resistance to antimicrobials, and the emergence of enteric pathogens. Predicted trending developments in the forecast period encompass molecular diagnostics, the incorporation of digital health, Artificial Intelligence and machine learning, as well as the use of syndromic testing and point-of-care testing.
View the full report here:
https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report
Top Growth Drivers in the Enteric Disease Testing Industry: What's Accelerating the Market?
The escalation in occurrences of diarrhea and hemolytic urea syndrome (HUS) is predicted to drive the expansion of the enteric disease testing market. The primary source of diarrhea cases is contaminated food and water intake. HUS, a disorder that impacts the blood and blood vessels, is most prevalent in children suffering from diarrhea. These two conditions are principal contributors to mortality rates in children below five years of age. This upswing in diarrhea and hemolytic instances warrants testing solutions, thereby boosting the need for enteric disease testing solutions. As per data from the Centers for Disease Control and Prevention, diarrhea ranks second in causing death in children below 5, with 801 thousand deaths worldwide, attributing to one in every nine child deaths annually. Consequently, the escalating instances of enteric diseases are expected to enhance the growth of the enteric disease testing market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6118&type=smp
What Trends Will Shape the Enteric Disease Testing Market Through 2029 and Beyond?
Leading firms in the enteric disease testing market are concentrating on the creation of superior diagnostic solutions like laboratory tools. These tools are specialized instruments utilized in scientific and medical labs to conduct tests, analyze samples, and yield accurate diagnostic data. They play a critical role in enhancing the accuracy of diagnostic procedures and aid research in several areas, including enteric disease testing. For example, Jiangsu Bioperfectus Technologies Co., Ltd., a biotechnology firm based in China, in March 2023, introduced real-time PCR kits purposed for diagnosing gastrointestinal infectious diseases. These kits offer heightened sensitivity and specificity, aiding in the accurate detection of reduced nucleic acid levels in different samples. Furthermore, they expedite the analysis process, significantly cutting down on processing times and enhancing throughput in diagnostic and research uses.
What Are the Main Segments in the Enteric Disease Testing Market?
The enteric disease testing market covered in this report is segmented -
1) By Disease Type: Bacterial Enteric Disease, Parasitic Enteric Disease, Viral Enteric Disease, Other Disease Types
2) By Technology: Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction (PCR), Immunoassay, Chromatography And Spectrometry, Other Technologies
3) By Application: Hospitals, Research Centers, Clinics, Other Applications
Subsegments:
1) By Bacterial Enteric Disease: Salmonella, Escherichia coli (E. coli), Shigella, Campylobacter, Clostridium Difficile (C. diff)
2) By Parasitic Enteric Disease: Giardia lamblia, Entamoeba histolytica, Cryptosporidium, Trichinella spiralis
3) By Viral Enteric Disease: Norovirus, Rotavirus, Adenovirus, Astrovirus
4) By Other Disease Types: Fungal Enteric Infections, Foodborne Illnesses, Antibiotic-Associated Diarrhea
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=6118&type=smp
Which Top Companies are Driving Growth in the Enteric Disease Testing Market?
Major companies operating in the enteric disease testing market include Becton Dickinson and Company, Biomerica Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Cepheid Inc., Coris Bioconcept, DiaSorin Molecular LLC, MMeridian Life Science Inc., Trinity Biotech plc., Abbott Laboratories, Fisher Scientific Inc., Alere Inc., 3M Company., Asure Quality, Bureau Veritas, Meridian Bioscience Inc., Hologic Inc., Luminex Corporation, Nanosphere Inc., Quidel Corporation, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., Vela Diagnostics, GenMark Diagnostics, BioFire Diagnostics LLC, Veredus Laboratories Pte Ltd.
Which Regions Will Dominate the Enteric Disease Testing Market Through 2029?
North America was the largest region in the enteric disease testing market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the enteric disease testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6118
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Top Market Shifts Transforming the Enteric Disease Testing Market Landscape: Key Insights here
News-ID: 4076859 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
